Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion

By Ward K. W.   Hardy L. B.   Kehler J. R.   Azzarano L. M.   Smith B. R.  

Xenobiotica, Vol. 34, Iss. 4, 2004-04 ,pp. : 367-377

Informa Healthcare

Access to resources Recommend Favorite

The Novel Neuropeptide Y Y₁ Receptor Antagonist J-104870: A Potent Feeding Suppressant with Oral Bioavailability

By Kanatani A.   Kanno T.   Ishihara A.   Hata M.   Sakuraba A.   Tanaka T.   Tsuchiya Y.   Mase T.   Fukuroda T.   Fukami T.   Ihara M.  

Biochemical and Biophysical Research Communications, Vol. 266, Iss. 1, 1999-12 ,pp. : 88-91

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

By Austin N. E.   Baldwin S. J.   Cutler L.   Deeks N.   Kelly P. J.   Nash M.   Shardlow C. E.   Stemp G.   Thewlis K.   Ayrton A.   Jeffrey P.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite

Absolute bioavailability and stereoselective pharmacokinetics of doxepin

By Yan J.-H.   Hubbard J. W.   McKay G.   Korchinski E. D.   Midha K. K.  

Xenobiotica, Vol. 32, Iss. 7, 2002-07 ,pp. : 615-623

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats

By Zhu Jing   Hu Yueqing   Ho Maurice K. C   Wong Yung H.  

Xenobiotica, Vol. 42, Iss. 11, 2012-11 ,pp. : 1138-1150

Informa Healthcare

Access to resources Recommend Favorite